| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.55 (Beat by $0.05) |
| EPS GAAP Actual | $0.55 (Beat by $0.05) |
| Revenue Actual | $-0.287469B |
| Revenue Surprise | Beat by $-287.469M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2028 | 2.32164 | 30.4 | 2.29926 | 2.34583 | 1 |
| Dec 2026 | 2.12725 | 33.17 | 2.11341 | 2.1461 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.55 | 0.55 | -0.287469B | 100% | -287.47M |
| FQ3 2025 (Jul 2025) | 0.52 | 0.52 | -0.145507B | 193.66% | -145.51M |
| FQ2 2025 (Apr 2025) | 0.52 | 0.52 | 0B | -INF% | 0M |
| FQ1 2025 (Jan 2025) | 0.46 | 0.46 | 0B | -INF% | 0M |
| FQ3 2024 (Sep 2024) | 0.51 | 0.51 | 0.136279B | 2.16% | 136.28M |
| FQ2 2024 (Jun 2024) | 0.57 | 0.57 | 0.140536B | 0.22% | 140.54M |
| FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 0.28214B | 50.27% | 282.14M |
| FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 0.236772B | 100% | 236.77M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.51 | -- | 0.5048 | 0.5152 | 1 |
| FQ4 2026 (Oct 2026) | 0.55689 | 1.24 | 0.54963 | 0.56863 | 1 |
| FQ3 2026 (Jul 2026) | 0.5809 | 10.48 | 0.57333 | 0.59315 | 1 |
| FQ2 2026 (Apr 2026) | 0.52097 | 0.19 | 0.51418 | 0.53195 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.15B | -- | 0.14B | 0.15B | 1 |
| FQ4 2026 (Oct 2026) | 0.14B | 302.37 | 0.14B | 0.14B | 1 |
| FQ3 2026 (Jul 2026) | 0.14B | 200.87 | 0.14B | 0.15B | 1 |
| FQ2 2026 (Apr 2026) | 0.14B | -- | 0.14B | 0.15B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
2
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.55 | 0.55 | 100% | |
| FQ3 2025 (Jul 2025) | 0.52 | 0.52 | 100% | |
| FQ2 2025 (Apr 2025) | 0.52 | 0.52 | 100% | |
| FQ1 2025 (Jan 2025) | 0.46 | 0.46 | 100% | |
| FQ3 2024 (Sep 2024) | 0.51 | 0.51 | 100% | |
| FQ2 2024 (Jun 2024) | 0.57 | 0.57 | 100% | |
| FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 100% | |
| FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $-0.29B | $-287.47M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $-0.15B | $-145.51M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Jan 2025) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0.14B | $136.28M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.14B | $140.54M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.28B | $282.14M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.24B | $236.77M | 100% |